CDK4/6 Inhibitors in Metastatic HR-Positive Breast Cancer
CDK4/6 Inhibitors in Metastatic HR-Positive Breast Cancer
Active, not recruiting · NCT07704801 · Registry updated 2026-07-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CDK4/6 Inhibitors in Metastatic HR-Positive Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not stated | 2026-07-15 | NCT07704801 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sohag University | 409 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sohag University Hospital | Sohag | Egypt | 62 |